Getting Funded: The Art and Science of Storytelling for the Life Science Company

April 2010Articles The Legal Eagle

“It was the best of times; it was the worst of times.”

Charles Dickens’ words from 150 years ago certainly apply to today’s funding environment. Life Sciences companies in particular face difficult challenges in raising capital due to the overall economic environment and the lengthy time required to bring products to market. Investors
are more critical and risk averse than ever before but they are also more open to great opportunities recognizing that tough times are often the catalyst for great innovation.

Demonstrating that your company is a great opportunity often depends on how well you tell your story, which is part art, part science. Venture capitalists will tell you that being well introduced matters.

Over the years I have worn many hats: legal counsel to investors and early stage companies and as an angel investor with Delaware Crossing Investor Group. The companies that were successful in getting funded, and getting funded again, share several key characteristics when they told their stories.